193 related articles for article (PubMed ID: 23416442)
1. Biodistribution and radiation dosimetry of [¹⁸F]-5-fluorouracil.
Hino-Shishikura A; Suzuki A; Minamimoto R; Shizukuishi K; Oka T; Tateishi U; Sugae S; Ichikawa Y; Horiuchi C; Inoue T
Appl Radiat Isot; 2013 May; 75():11-7. PubMed ID: 23416442
[TBL] [Abstract][Full Text] [Related]
2. Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human Study.
Bretin F; Bahri MA; Bernard C; Warnock G; Aerts J; Mestdagh N; Buchanan T; Otoul C; Koestler F; Mievis F; Giacomelli F; Degueldre C; Hustinx R; Luxen A; Seret A; Plenevaux A; Salmon E
Mol Imaging Biol; 2015 Aug; 17(4):557-64. PubMed ID: 25595813
[TBL] [Abstract][Full Text] [Related]
3. Imaging of the striatal and extrastriatal dopamine transporter with (18)F-LBT-999: quantification, biodistribution, and radiation dosimetry in nonhuman primates.
Varrone A; Stepanov V; Nakao R; Tóth M; Gulyás B; Emond P; Deloye JB; Vercouillie J; Stabin MG; Jonsson C; Guilloteau D; Halldin C
J Nucl Med; 2011 Aug; 52(8):1313-21. PubMed ID: 21764797
[TBL] [Abstract][Full Text] [Related]
4. Radiation dosimetry estimation of N-(2-[(18)F]fluoropropionyl)- L-glutamate based on the mice distribution data.
Tang C; Xu Z; Hu K; Yao B; Tang G; Nie D
Appl Radiat Isot; 2015 Apr; 98():108-12. PubMed ID: 25661723
[TBL] [Abstract][Full Text] [Related]
5. Fluorine-18-labeled 5-fluorouracil is a useful radiotracer for differentiation of malignant tumors from inflammatory lesions.
Sugae S; Suzuki A; Takahashi N; Minamimoto R; Cheng C; Theeraladanon C; Endo I; Togo S; Inoue T; Shimada H
Ann Nucl Med; 2008 Jan; 22(1):65-72. PubMed ID: 18250989
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution, Tumor Detection, and Radiation Dosimetry of
Young CR; Adler S; Eary JF; Lindenberg ML; Jacobs PM; Collins J; Kummar S; Kurdziel KA; Choyke PL; Mena E
J Nucl Med; 2019 Apr; 60(4):492-496. PubMed ID: 30389817
[TBL] [Abstract][Full Text] [Related]
7. Assessment of human biodistribution and dosimetry of 4-fluoro-11beta-methoxy-16alpha-18F-fluoroestradiol using serial whole-body PET/CT.
Beauregard JM; Croteau E; Ahmed N; van Lier JE; Bénard F
J Nucl Med; 2009 Jan; 50(1):100-7. PubMed ID: 19091905
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution and radiation dosimetry of the integrin marker 18F-RGD-K5 determined from whole-body PET/CT in monkeys and humans.
Doss M; Kolb HC; Zhang JJ; Bélanger MJ; Stubbs JB; Stabin MG; Hostetler ED; Alpaugh RK; von Mehren M; Walsh JC; Haka M; Mocharla VP; Yu JQ
J Nucl Med; 2012 May; 53(5):787-95. PubMed ID: 22499613
[TBL] [Abstract][Full Text] [Related]
9. Direct comparison of radiation dosimetry of six PET tracers using human whole-body imaging and murine biodistribution studies.
Sakata M; Oda K; Toyohara J; Ishii K; Nariai T; Ishiwata K
Ann Nucl Med; 2013 Apr; 27(3):285-96. PubMed ID: 23404061
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution and radiation dosimetry of [18F]F-PEB in nonhuman primates.
Bélanger MJ; Krause SM; Ryan C; Sanabria-Bohorquez S; Li W; Hamill TG; Burns HD
Nucl Med Commun; 2008 Oct; 29(10):915-9. PubMed ID: 18769310
[TBL] [Abstract][Full Text] [Related]
11. Biodistribution and Radiation Dosimetry for the Tau Tracer
Hsiao IT; Lin KJ; Huang KL; Huang CC; Chen HS; Wey SP; Yen TC; Okamura N; Hsu JL
J Nucl Med; 2017 Sep; 58(9):1498-1503. PubMed ID: 28336780
[No Abstract] [Full Text] [Related]
12. Radiation dosimetry of 89Zr-labeled chimeric monoclonal antibody U36 as used for immuno-PET in head and neck cancer patients.
Börjesson PK; Jauw YW; de Bree R; Roos JC; Castelijns JA; Leemans CR; van Dongen GA; Boellaard R
J Nucl Med; 2009 Nov; 50(11):1828-36. PubMed ID: 19837762
[TBL] [Abstract][Full Text] [Related]
13. Radiation dosimetry and biodistribution of the hypoxia tracer (18)F-EF5 in oncologic patients.
Lin LL; Silvoniemi A; Stubbs JB; Rengan R; Suilamo S; Solin O; Divgi C; Eskola O; Sorger JM; Stabin MG; Kachur A; Hahn SM; Grönroos TJ; Forsback S; Evans SM; Koch CJ; Minn H
Cancer Biother Radiopharm; 2012 Sep; 27(7):412-9. PubMed ID: 22897720
[TBL] [Abstract][Full Text] [Related]
14. Radiation dosimetry of [
Lee N; Oh I; Chae SY; Jin S; Oh SJ; Lee SJ; Koglin N; Berndt M; Stephens AW; Oh JS; Moon DH
Nucl Med Biol; 2019; 72-73():45-48. PubMed ID: 31330411
[TBL] [Abstract][Full Text] [Related]
15. Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteers.
Doss M; Kolb HC; Walsh JC; Mocharla V; Fan H; Chaudhary A; Zhu Z; Alpaugh RK; Lango MN; Yu JQ
J Nucl Med; 2013 Dec; 54(12):2087-92. PubMed ID: 24136934
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of [18F]Mefway biodistribution and dosimetry based on whole-body PET imaging of mice.
Constantinescu CC; Sevrioukov E; Garcia A; Pan ML; Mukherjee J
Mol Imaging Biol; 2013 Apr; 15(2):222-9. PubMed ID: 22833323
[TBL] [Abstract][Full Text] [Related]
17. Improved accuracy of the biodistribution and internal radiation dosimetry of
Yu X; Sun H; Xu L; Han Y; Wang C; Li L; Ng YL; Shi F; Qiu J; Huang G; Zhou Y; Chen Y; Liu J
Med Phys; 2023 Sep; 50(9):5865-5874. PubMed ID: 37177847
[TBL] [Abstract][Full Text] [Related]
18.
Nishii R; Higashi T; Kagawa S; Okuyama C; Kishibe Y; Takahashi M; Okina T; Suzuki N; Hasegawa H; Nagahama Y; Ishizu K; Oishi N; Kimura H; Watanabe H; Ono M; Saji H; Yamauchi H
Ann Nucl Med; 2018 May; 32(4):256-263. PubMed ID: 29453681
[TBL] [Abstract][Full Text] [Related]
19. Biodistribution and radiation dosimetry of [123I]ADAM in healthy human subjects: preliminary results.
Kauppinen TA; Bergström KA; Heikman P; Hiltunen J; Ahonen AK
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):132-6. PubMed ID: 12483421
[TBL] [Abstract][Full Text] [Related]
20. Human biodistribution and dosimetry of the PET perfusion agent copper-62-PTSM.
Wallhaus TR; Lacy J; Whang J; Green MA; Nickles RJ; Stone CK
J Nucl Med; 1998 Nov; 39(11):1958-64. PubMed ID: 9829589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
